Tags

Oncology therapy targeting

Solstice Oncology secures $225 million series A for immuno-oncology therapy

Solstice Oncology secures $225 million series A for immuno-oncology therapy

September 10, 2026 | 14:46
Harbour BioMed partner Solstice Oncology secured $225 million in Series A financing to advance porustobart, a novel neoadjuvant immuno-oncology therapy targeting diverse cancer treatments.

Latest News

Beyond digital: Why Asia's hospitals are racing to get connected?

Beyond digital: Why Asia's hospitals are racing to get connected?

Vietnam proposes lowering import tax exemption threshold to $4

Vietnam proposes lowering import tax exemption threshold to $4

HR Path acquires tts digital HR experts to expand SAP consulting

HR Path acquires tts digital HR experts to expand SAP consulting

Sceye completes 30,000 km stratospheric flight testing direct-to-device coverage

Sceye completes 30,000 km stratospheric flight testing direct-to-device coverage

Vietnam Investment Review under the Ministry of Finance

Editor-in-Chief: Pham Van Hoanh

Deputy Editors-in-Chief: Le Trong Minh, Ngo Chi Tung, Nguyen Van Hong

Managing Editor: Nguyen Chi Mai

Advertisement  | Contact us

Based on MasterCMS Ultimate Edition 2026 v2.9
Corporate CEO Talk Biz Link PR Newswire Media OutReach Newswire
Investing M&A Outbound Investment Investing in Haiphong
Your Consultant KPMG PwC Indochine Counsel Vilasia Ansarada
Green Growth Energy Efficiency Rethinking Plastics BASF
Property Green Buildings Industrial Properties
Money Insurance Smart Payment Trends Stock Monitor
Infographics
Timeout Travel Hotels & Restaurants The Insider Entertainment Lifestyle
Sports
Photos
Society Swing for the Kids CSR
World News
virs-publications-vir
timeout-vn
ptbv2020